Kodiak Sciences (KOD) Interest Expenses (2017 - 2023)
Kodiak Sciences (KOD) reported Interest Expenses of $5000.0 for Q3 2023, up 25.0% on a YoY basis from $4000.0 in Q3 2022, and up 25.0% quarter-over-quarter from $4000.0 in Q2 2023.
Kodiak Sciences (KOD) Interest Expenses (2017 - 2023) Analysis & Trends
Kodiak Sciences has reported Interest Expenses for 7 years, with the latest figure at $5000.0 in Q3 2023.
- For the quarter ending Q3 2023, Interest Expenses rose 25.0% year-over-year to $5000.0; the trailing twelve-month figure through Jun 2024 stood at $5000.0 (down 68.75% YoY), and the FY2023 full-year result was $13000.0, down 27.78% from the prior year.
- Interest Expenses for Q3 2023 stood at $5000.0, up from $4000.0 in the prior quarter.
- The five-year high for Interest Expenses was $30000.0 in Q4 2021, with the low at $2000.0 in Q2 2019.
- Historically, Interest Expenses has averaged $6166.7 across 5 years, with a median of $5000.0 in 2021.
- Annual changes were most pronounced in 2019 — Interest Expenses slumped 99.81% — and 2021, when it soared 400.0%.
- Kodiak Sciences' Interest Expenses stood at $2000.0 in 2019, then surged by 200.0% to $6000.0 in 2020, then soared by 400.0% to $30000.0 in 2021, then slumped by 86.67% to $4000.0 in 2022, then climbed by 25.0% to $5000.0 in 2023.
- The last three Interest Expenses figures came in at $5000.0 (Q3 2023), $4000.0 (Q2 2023), and $4000.0 (Q1 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | -5.50 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | 61,000.00 |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | -332,000.00 |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | -2,753.00 |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | -5.58 Mn |
| 10 | Kodiak Sciences | 1.95 Bn | 1.95 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 5,000.00 |
| Sep 30, 2023 | 5,000.00 |
| Jun 30, 2023 | 4,000.00 |
| Jun 30, 2023 | 4,000.00 |
| Mar 31, 2023 | 4,000.00 |
| Mar 31, 2023 | 4,000.00 |
| Dec 31, 2022 | 4,000.00 |
| Dec 31, 2022 | 4,000.00 |
| Sep 30, 2022 | 4,000.00 |
| Sep 30, 2022 | 4,000.00 |
| Jun 30, 2022 | 5,000.00 |
| Jun 30, 2022 | 5,000.00 |
| Mar 31, 2022 | 5,000.00 |
| Mar 31, 2022 | 5,000.00 |
| Dec 31, 2021 | 30,000.00 |
| Dec 31, 2021 | 30,000.00 |
| Sep 30, 2021 | 6,000.00 |
| Sep 30, 2021 | 6,000.00 |
| Jun 30, 2021 | 5,000.00 |
| Jun 30, 2021 | 5,000.00 |